Powder: -20°C for 3 years | In solvent: -80°C for 1 year
UK-371804 is an effective and specific uPA inhibitor. It was selected as a candidate for further preClinicalal evaluation for the treatment of chronic dermal ulcers.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 44.00 | |
2 mg | In stock | $ 61.00 | |
5 mg | In stock | $ 110.00 | |
10 mg | In stock | $ 189.00 | |
25 mg | In stock | $ 341.00 | |
50 mg | In stock | $ 512.00 | |
100 mg | In stock | $ 743.00 | |
500 mg | In stock | $ 1,550.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 119.00 |
Description | UK-371804 is an effective and specific uPA inhibitor. It was selected as a candidate for further preClinicalal evaluation for the treatment of chronic dermal ulcers. |
Targets&IC50 | uPA:10 nM. (Ki) |
In vitro | In the acute excision wound model in pigs, topical administration of UK-3718046 penetrates porcine wounds and inhibits exogenous uPA activity without adverse effects on wound-healing parameters. |
In vivo | In vitro studies have shown that UK-3718046 is an inhibitor of exogenous uPA in human chronic wound fluid, displaying inhibitory capabilities with an IC50 of 0.89 μM. |
Synonyms | UK371804 |
Molecular Weight | 385.83 |
Formula | C14H16ClN5O4S |
CAS No. | 256477-09-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 10 mg/mL (25.92 mM), Sonification and heating are recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
UK-371804 256477-09-5 Metabolism Proteases/Proteasome PAI-1 Serine Protease Inhibitor UK 371804 inhibit Plasminogen activator inhibitor-1 UK371804 inhibitor